FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

773879000: Antineoplastic therapeutic role (role)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3726859011 Antineoplastic therapeutic role en Synonym Active Entire term case insensitive SNOMED CT core module
3726860018 Antineoplastic therapeutic role (role) en Fully specified name Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Antineoplastic therapeutic role Is a Therapeutic role true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Binimetinib 15mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Encorafenib 75mg capsules Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Niraparib 100mg capsules Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Selumetinib 10mg capsules Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Selinexor 20mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Lorlatinib 100mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Pembrolizumab 100mg/4ml solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Pemetrexed 750mg/100ml infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Eribulin 1320micrograms/3ml solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Dacomitinib 15mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Sotorasib 120mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Amivantamab 350mg/7ml solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Cyproterone 2mg capsules Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Pemetrexed 900mg/100ml infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Larotrectinib 100mg capsules Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Inotuzumab ozogamicin 1mg powder for solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Pemigatinib 9mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Tafasitamab 200mg powder for solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Ixazomib 2.3mg capsules Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Polatuzumab vedotin 140mg powder for solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Cyproterone 25mg/5ml oral suspension Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Brexucabtagene autoleucel 40million-200million cells/68ml dispersion for infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Talazoparib 250microgram capsules Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Abemaciclib 100mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Trastuzumab emtansine 100mg powder for solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Sacituzumab govitecan 180mg powder for solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Pemetrexed 1g/100ml infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Alectinib 150mg capsules Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Encorafenib 50mg capsules Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Entrectinib 200mg capsules Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Dostarlimab 500mg/10ml solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Pemetrexed 700mg/100ml infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Isatuximab 500mg/25ml solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Brigatinib 90mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Elotuzumab 300mg powder for solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Atezolizumab 1.2g/20ml solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Pemigatinib 13.5mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Venetoclax 10mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Atezolizumab 1.2g/250ml infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Abemaciclib 50mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Glasdegib 100mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Entrectinib 100mg capsules Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Larotrectinib 20mg/ml oral solution sugar free Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Elotuzumab 400mg powder for solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Axicabtagene ciloleucel 40million-200million cells/68ml dispersion for infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Cabozantinib 60mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Gilteritinib 40mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Fedratinib 100mg capsules Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Alpelisib 50mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Tepotinib 225mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Palbociclib 125mg capsules Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Brigatinib 30mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Cyproterone 10mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Alpelisib 50mg tablets and Alpelisib 200mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Selpercatinib 40mg capsules Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Osimertinib 40mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Alpelisib 150mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Talimogene laherparepvec 100million plaque forming units/1ml solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Daratumumab 100mg/5ml solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Trifluridine 15mg / Tipiracil 6.14mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Acalabrutinib 100mg capsules Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Trastuzumab emtansine 160mg powder for solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Isatuximab 100mg/5ml solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Darolutamide 300mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Blinatumomab 38.5micrograms powder and solvent for solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Tucatinib 150mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Dacomitinib 30mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Pemetrexed 800mg/100ml infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Osimertinib 80mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Cabozantinib 80mg capsules Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Brigatinib 90mg tablets and Brigatinib 180mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Tivozanib 890microgram capsules Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Dacomitinib 45mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Pralsetinib 100mg capsules Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Abemaciclib 150mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Brigatinib 180mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Talazoparib 1mg capsules Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Larotrectinib 20mg/ml oral solution Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Venetoclax 100mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Vinflunine 50mg/2ml solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Pemetrexed 600mg/100ml infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Glasdegib 25mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Pemetrexed 1.1g/100ml infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Palbociclib 75mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Larotrectinib 25mg capsules Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Polatuzumab vedotin 30mg powder for solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Olaratumab 500mg/50ml solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Enfortumab vedotin 20mg powder for solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Cyproterone 300mg/3ml solution for injection ampoules Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Trastuzumab deruxtecan 100mg powder for solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Zanubrutinib 80mg capsules Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Belantamab mafodotin 100mg powder for solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Tivozanib 1340microgram capsules Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Tucatinib 50mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Avapritinib 200mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Palbociclib 125mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Midostaurin 25mg capsules Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Lorlatinib 25mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Pemigatinib 4.5mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Talimogene laherparepvec 1million plaque forming units/1ml solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Avelumab 200mg/10ml solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier

Start Previous Page 25 of 26 End

This concept is not in any reference sets

Back to Start